$SNDK stock fell 14% this week, according to our price data from Polygon.
It has been the 42nd most-searched ticker on Quiver Quantitative over the last week, out of 50 total tickers searched.
Here is what we see in our data on $SNDK (you can track the company live on Quiver's $SNDK stock page):
$SNDK Insider Trading Activity
$SNDK insiders have traded $SNDK stock on the open market 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $SNDK stock by insiders over the last 6 months:
- MIYUKI SUZUKI sold 3,500 shares for an estimated $2,196,359
- NECIP SAYINER sold 1,271 shares for an estimated $248,026
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$SNDK Hedge Fund Activity
We have seen 464 institutional investors add shares of $SNDK stock to their portfolio, and 286 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BLACKROCK, INC. removed 6,418,316 shares (-40.0%) from their portfolio in Q4 2025, for an estimated $1,523,579,852
- SLATE PATH CAPITAL LP removed 2,693,657 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $639,420,298
- PRICE T ROWE ASSOCIATES INC /MD/ removed 1,870,903 shares (-56.6%) from their portfolio in Q4 2025, for an estimated $444,114,954
- NEUBERGER BERMAN GROUP LLC removed 1,226,094 shares (-70.8%) from their portfolio in Q4 2025, for an estimated $291,050,193
- GEODE CAPITAL MANAGEMENT, LLC added 1,133,276 shares (+44.9%) to their portfolio in Q4 2025, for an estimated $269,017,056
- QUBE RESEARCH & TECHNOLOGIES LTD added 1,082,597 shares (+inf%) to their portfolio in Q4 2025, for an estimated $256,986,875
- EVERGREEN QUALITY FUND GP, LTD. added 1,077,800 shares (+inf%) to their portfolio in Q4 2025, for an estimated $255,848,164
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$SNDK Congressional Stock Trading
Members of Congress have traded $SNDK stock 4 times in the past 6 months. Of those trades, 2 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $SNDK stock by members of Congress over the last 6 months:
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. purchased up to $15,000 on 01/09.
- REPRESENTATIVE LISA C. MCCLAIN has traded it 3 times. They made 1 purchase worth up to $15,000 on 10/30 and 2 sales worth up to $30,000 on 10/31, 10/30.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$SNDK Analyst Ratings
Wall Street analysts have issued reports on $SNDK in the last several months. We have seen 11 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- KGI Securities issued a "Outperform" rating on 03/18/2026
- Cantor Fitzgerald issued a "Overweight" rating on 01/30/2026
- Wedbush issued a "Outperform" rating on 01/30/2026
- Jefferies issued a "Buy" rating on 01/30/2026
- Citigroup issued a "Buy" rating on 01/20/2026
- Benchmark issued a "Buy" rating on 01/15/2026
- Mizuho issued a "Outperform" rating on 01/09/2026
To track analyst ratings and price targets for $SNDK, check out Quiver Quantitative's $SNDK forecast page.
$SNDK Price Targets
Multiple analysts have issued price targets for $SNDK recently. We have seen 17 analysts offer price targets for $SNDK in the last 6 months, with a median target of $690.0.
Here are some recent targets:
- Wamsi Mohan from B of A Securities set a target price of $900.0 on 03/23/2026
- Asiya Merchant from Citigroup set a target price of $875.0 on 03/19/2026
- An analyst from KGI Securities set a target price of $992.0 on 03/18/2026
- Thomas O'Malley from Barclays set a target price of $750.0 on 02/02/2026
- Joseph Moore from Morgan Stanley set a target price of $690.0 on 01/30/2026
- Blayne Curtis from Jefferies set a target price of $700.0 on 01/30/2026
- James Schneider from Goldman Sachs set a target price of $700.0 on 01/30/2026
You can track data on $SNDK on Quiver Quantitative.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
